The translation initiation factor 3 subunit eIF3K interacts with PML and associates with PML nuclear bodies

Experimental Cell Research

Volumn 319, Issue 17, 2013, Pages 2554-2565

  Salsman, Jayme ^a   Pinder, Jordan ^a   Tse, Brenda ^a   Corkery, Dale ^b   Dellaire, Graham ^a,b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

EIF3K; Light microscopy; Nuclear structure; PML; Yeast two hybrid

Indexed keywords

INITIATION FACTOR 3; INITIATION FACTOR 3 SUBUNIT K 2; PROMYELOCYTIC LEUKEMIA PROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN 1; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; ARTICLE; CELL NUCLEUS INCLUSION BODY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; NUCLEOTIDE SEQUENCE; PEPTIDE MAPPING; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SUBUNIT; SCREENING; TWO HYBRID SYSTEM;

EUKARYOTA;

EID: 84885350529     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2013.09.001     Document Type: Article

References (60)

1. Andrade M.A., Petosa C., O'Donoghue S.I., Muller C.W., Bork P. Comparison of ARM and HEAT protein repeats. J. Mol. Biol. 2001, 309:1-18.
2. Asano K., Kinzy T.G., Merrick W.C., Hershey J.W. Conservation and diversity of eukaryotic translation initiation factor eIF3. J. Biol. Chem. 1997, 272:1101-1109.
3. Ascoli C.A., Maul G.G. Identification of a novel nuclear domain. J. Cell Biol. 1991, 112:785-795.
4. Bernardi R., Pandolfi P.P. Role of PML and the PML-nuclear body in the control of programmed cell death. Oncogene 2003, 22:9048-9057.
5. Bernardi R., Pandolfi P.P. Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat. Rev. Mol. Cell Biol. 2007, 8:1006-1016.
6. Borden K.L. RING fingers and B-boxes: zinc-binding protein-protein interaction domains. Biochem. Cell Biol. 1998, 76:351-358.
7. Browning K.S., Gallie D.R., Hershey J.W., Hinnebusch A.G., Maitra U., Merrick W.C., Norbury C. Unified nomenclature for the subunits of eukaryotic initiation factor 3. Trends Biochem. Sci. 2001, 26:284.
8. Burke D., Dawson D., Stearns T. Methods in Yeast Genetics: A Cold Spring Harbor Laboratory Course Manual 2000, Cold Spring Harbor Laboratory Press, Woodbury, New York.
9. Condemine W., Takahashi Y., Le Bras M., de Thé H. A nucleolar targeting signal in PML-I addresses PML to nucleolar caps in stressed or senescent cells. J. Cell Sci. 2007, 120:3219-3227.
10. Condemine W., Takahashi Y., Zhu J., Puvion-Dutilleul F., Guegan S., Janin A., de Thé H. Characterization of endogenous human promyelocytic leukemia isoforms. Cancer Res. 2006, 66:6192-6198.
11. De Martelaere K., Lintermans B., Haegeman G., Vanhoenacker P. Novel interaction between the human 5-HT7 receptor isoforms and PLAC-24/eIF3k. Cell. Signal. 2007, 19:278-288.
12. de Thé H., Lavau C., Marchio A., Chomienne C., Degos L., Dejean A. The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 1991, 66:675-684.
13. Dellaire G., Bazett-Jones D.P. PML nuclear bodies: dynamic sensors of DNA damage and cellular stress. Bioessays 2004, 26:963-977.
14. Dellaire G., Ching R.W., Dehghani H., Ren Y., Bazett-Jones D.P. The number of PML nuclear bodies increases in early S phase by a fission mechanism. J. Cell Sci. 2006, 119:1026-1033.
15. Dellaire G., Farrall R., Bickmore W.A. The nuclear protein database (NPD): sub-nuclear localisation and functional annotation of the nuclear proteome. Nucleic Acids Res. 2003, 31:328-330.
16. Dellaire G., Makarov E.M., Cowger J.J., Longman D., Sutherland H.G., Luhrmann R., Torchia J., Bickmore W.A. Mammalian PRP4 kinase copurifies and interacts with components of both the U5 snRNP and the N-CoR deacetylase complexes. Mol. Cell Biol. 2002, 22:5141-5156.
17. Desbois C., Rousset R., Bantignies F., Jalinot P. Exclusion of Int-6 from PML nuclear bodies by binding to the HTLV-I Tax oncoprotein. Science 1996, 273:951-953.
18. Eskiw C.H., Dellaire G., Bazett-Jones D.P. Chromatin contributes to structural integrity of promyelocytic leukemia bodies through a SUMO-1-independent mechanism. J. Biol. Chem. 2004, 279:9577-9585.
19. Everett R.D., Lomonte P., Sternsdorf T., van Driel R., Orr A. Cell cycle regulation of PML modification and ND10 composition. J. Cell Sci. 1999, 112(Pt 24):4581-4588.
20. Fagioli M., Alcalay M., Pandolfi P.P., Venturini L., Mencarelli A., Simeone A., Acampora D., Grignani F., Pelicci P.G. Alternative splicing of PML transcripts predicts coexpression of several carboxy-terminally different protein isoforms. Oncogene 1992, 7:1083-1091.
21. Fogal V., Gostissa M., Sandy P., Zacchi P., Sternsdorf T., Jensen K., Pandolfi P.P., Will H., Schneider C., Del S.G. Regulation of p53 activity in nuclear bodies by a specific PML isoform. EMBO J. 2000, 19:6185-6195.
22. Freemont P.S. The RING finger. A novel protein sequence motif related to the zinc finger. Ann. N. Y. Acad. Sci. 1993, 684:174-192.
23. Gietz R.D., Schiestl R.H., Willems A.R., Woods R.A. Studies on the transformation of intact yeast cells by the LiAc/SS-DNA/PEG procedure. Yeast 1995, 11:355-360.
24. Guo A., Salomoni P., Luo J., Shih A., Zhong S., Gu W., Pandolfi P.P. The function of PML in p53-dependent apoptosis. Nat. Cell Biol. 2000, 2:730-736.
25. Gurrieri C., Capodieci P., Bernardi R., Scaglioni P.P., Nafa K., Rush L.J., Verbel D.A., Cordon-Cardo C., Pandolfi P.P. Loss of the tumor suppressor PML in human cancers of multiple histologic origins. J. Natl. Cancer Inst. 2004, 96:269-279.
26. Henderson B.R., Eleftheriou A. A comparison of the activity, sequence specificity, and CRM1-dependence of different nuclear export signals. Exp. Cell Res. 2000, 256:213-224.
27. Hershey J.W., Asano K., Naranda T., Vornlocher H.P., Hanachi P., Merrick W.C. Conservation and diversity in the structure of translation initiation factor EIF3 from humans and yeast. Biochimie 1996, 78:903-907.
28. Ishov A.M., Sotnikov A.G., Negorev D., Vladimirova O.V., Neff N., Kamitani T., Yeh E.T., Strauss J.F., Maul G.G. PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J. Cell Biol. 1999, 147:221-234.
29. Jensen K., Shiels C., Freemont P.S. PML protein isoforms and the RBCC/TRIM motif. Oncogene 2001, 20:7223-7233.
30. Kamitani T., Kito K., Nguyen H.P., Wada H., Fukuda-Kamitani T., Yeh E.T. Identification of three major sentrinization sites in PML. J. Biol. Chem. 1998, 273:26675-26682.
31. Karki S., Ligon L.A., DeSantis J., Tokito M., Holzbaur E.L. PLAC-24 is a cytoplasmic dynein-binding protein that is recruited to sites of cell-cell contact. Mol. Biol. Cell 2002, 13:1722-1734.
32. Koken M.H., Puvion-Dutilleul F., Guillemin M.C., Viron A., Linares-Cruz G., Stuurman N., de Jong L., Szostecki C., Calvo F., Chomienne C. The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion. EMBO J. 1994, 13:1073-1083.
33. Lai H.K., Borden K.L. The promyelocytic leukemia (PML) protein suppresses cyclin D1 protein production by altering the nuclear cytoplasmic distribution of cyclin D1 mRNA. Oncogene 2000, 19:1623-1634.
34. Lin H.K., Bergmann S., Pandolfi P.P. Cytoplasmic PML function in TGF-beta signaling. Nature 2004, 431:205-211.
35. Lin Y.M., Chen Y.R., Lin J.R., Wang W.J., Inoko A., Inagaki M., Wu Y.C., Chen R.H. eIF3k Regulates apoptosis in epithelial cells by releasing caspase 3 from keratin-containing inclusions. J. Cell Sci. 2008, 121:2382-2393.
36. Masutani M., Sonenberg N., Yokoyama S., Imataka H. Reconstitution reveals the functional core of mammalian eIF3. EMBO J. 2007, 26:3373-3383.
37. Maul G.G. Nuclear domain 10, the site of DNA virus transcription and replication. Bioessays 1998, 20:660-667.
38. Mayeur G.L., Fraser C.S., Peiretti F., Block K.L., Hershey J.W. Characterization of eIF3k: a newly discovered subunit of mammalian translation initiation factor elF3. Eur. J. Biochem. 2003, 270:4133-4139.
39. Morris-Desbois C., Bochard V., Reynaud C., Jalinot P. Interaction between the Ret finger protein and the Int-6 gene product and co-localisation into nuclear bodies. J. Cell Sci. 1999, 112(Pt 19):3331-3342.
40. Negorev D., Maul G.G. Cellular proteins localized at and interacting within ND10/PML nuclear bodies/PODs suggest functions of a nuclear depot. Oncogene 2001, 20:7234-7242.
41. Nguyen L.A., Pandolfi P.P., Aikawa Y., Tagata Y., Ohki M., Kitabayashi I. Physical and functional link of the leukemia-associated factors AML1 and PML. Blood 2005, 105:292-300.
42. Phan L., Zhang X., Asano K., Anderson J., Vornlocher H.P., Greenberg J.R., Qin J., Hinnebusch A.G. Identification of a translation initiation factor 3 (eIF3) core complex, conserved in yeast and mammals, that interacts with eIF5. Mol. Cell. Biol. 1998, 18:4935-4946.
43. Pick E., Hofmann K., Glickman M.H. PCI complexes: beyond the proteasome, CSN, and eIF3 Troika. Mol. Cell 2009, 35:260-264.
44. Reymond A., Meroni G., Fantozzi A., Merla G., Cairo S., Luzi L., Riganelli D., Zanaria E., Messali S., Cainarca S., Guffanti A., Minucci S., Pelicci P.G., Ballabio A. The tripartite motif family identifies cell compartments. EMBO J. 2001, 20:2140-2151.
45. Salomoni P., Pandolfi P.P. The role of PML in tumor suppression. Cell 2002, 108:165-170.
46. Sambrook J., Fritsch E.F., Maniatis T. Molecular Cloning: A Laboratory Manual 1989, Cold Spring Harbor Laboratory Press.
47. Shen T.H., Lin H.K., Scaglioni P.P., Yung T.M., Pandolfi P.P. The mechanisms of PML-nuclear body formation. Mol. Cell 2006, 24:331-339.
48. Shen X., Yang Y., Liu W., Sun M., Jiang J., Zong H., Gu J. Identification of the p28 subunit of eukaryotic initiation factor 3(eIF3k) as a new interaction partner of cyclin D3. FEBS Lett. 2004, 573:139-146.
49. Shi J., Hershey J.W., Nelson M.A. Phosphorylation of the eukaryotic initiation factor 3f by cyclin-dependent kinase 11 during apoptosis. FEBS Lett. 2009, 583:971-977.
50. Sternsdorf T., Jensen K., Reich B., Will H. The nuclear dot protein sp100, characterization of domains necessary for dimerization, subcellular localization, and modification by small ubiquitin-like modifiers. J. Biol. Chem. 1999, 274:12555-12566.
51. Sternsdorf T., Jensen K., Will H. Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1. J. Cell Biol. 1997, 139:1621-1634.
52. Strausberg R.L., Feingold E.A., Grouse L.H., Derge J.G., Klausner R.D., Collins F.S., Wagner L., Shenmen C.M., Schuler G.D., Altschul S.F., Zeeberg B., Buetow K.H., Schaefer C.F., Bhat N.K., Hopkins R.F., Jordan H., Moore T., Max S.I., Wang J., Hsieh F., Diatchenko L., Marusina K., Farmer A.A., Rubin G.M., Hong L., Stapleton M., Soares M.B., Bonaldo M.F., Casavant T.L., Scheetz T.E., Brownstein M.J., Usdin T.B., Toshiyuki S., Carninci P., Prange C., Raha S.S., Loquellano N.A., Peters G.J., Abramson R.D., Mullahy S.J., Bosak S.A., McEwan P.J., McKernan K.J., Malek J.A., Gunaratne P.H., Richards S., Worley K.C., Hale S., Garcia A.M., Gay L.J., Hulyk S.W., Villalon D.K., Muzny D.M., Sodergren E.J., Lu X., Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S., Sanchez A., Whiting M., Madan A., Young A.C., Shevchenko Y., Bouffard G.G., Blakesley R.W., Touchman J.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J., Schmutz J., Myers R.M., Butterfield Y.S., Krzywinski M.I., Skalska U., Smailus D.E., Schnerch A., Schein J.E., Jones S.J., Marra M.A. Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc. Natl. Acad. Sci. USA 2002, 99:16899-16903.
53. Ulbricht T., Alzrigat M., Horch A., Reuter N., von Mikecz A., Steimle V., Schmitt E., Kramer O.H., Stamminger T., Hemmerich P. PML promotes MHC class II gene expression by stabilizing the class II transactivator. J. Cell Biol. 2012, 199:49-63.
54. Van Damme E., Laukens K., Dang T.H., Van Ostade X. A manually curated network of the PML nuclear body interactome reveals an important role for PML-NBs in SUMOylation dynamics. Int. J. Biol. Sci. 2010, 6:51-67.
55. Vernier M., Bourdeau V., Gaumont-Leclerc M.F., Moiseeva O., Begin V., Saad F., Mes-Masson A.M., Ferbeyre G. Regulation of E2Fs and senescence by PML nuclear bodies. Genes Dev. 2011, 25:41-50.
56. Wang Z.G., Delva L., Gaboli M., Rivi R., Giorgio M., Cordon-Cardo C., Grosveld F., Pandolfi P.P. Role of PML in cell growth and the retinoic acid pathway. Science 1998, 279:1547-1551.
57. Wei Z., Zhang P., Zhou Z., Cheng Z., Wan M., Gong W. Crystal structure of human eIF3k, the first structure of eIF3 subunits. J. Biol. Chem. 2004, 279:34983-34990.
58. Yu J., Lan J., Wang C., Wu Q., Zhu Y., Lai X., Sun J., Jin C., Huang H. PML3 interacts with TRF1 and is essential for ALT-associated PML bodies assembly in U2OS cells. Cancer Lett. 2010, 291:177-186.
59. Zhong S., Hu P., Ye T.Z., Stan R., Ellis N.A., Pandolfi P.P. A role for PML and the nuclear body in genomic stability. Oncogene 1999, 18:7941-7947.
60. Zhong S., Salomoni P., Pandolfi P.P. The transcriptional role of PML and the nuclear body. Nat. Cell Biol. 2000, 2:E85-E90.